BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 12, 2013
View Archived Issues
Astellas Pharma offers overview of second quarter of fiscal 2013
Read More
AstraZeneca reviews key events of third quarter 2013
Read More
KSR2 mutations associated with obesity and impaired glucose control in humans
Read More
New conjugates of mutated rFGF-1 and metal nanoparticles disclosed by Polish group
Read More
Alfact Innovation presents phase II results for ALF-5755 in AIH/HBV-related liver disease
Read More
STAT3 inhibitor SH-4-54 active against breast cancer, multiple myeloma and brain cancer
Read More
Sanofi presents preclinical results for SAR-502250
Read More
Bispecific TNF/IL-17A inhibitor engineered for rheumatoid arthritis
Read More
Clinuvel Pharmaceuticals reports data from U.S. phase III study of Scenesse
Read More
Zalicus to discontinue Z-160 development following phase II results
Read More
DengueCide receives EMA orphan drug designation
Read More
Omeros reports data from phase I trial of OMS-721
Read More
Keryx Biopharmaceuticals provides update from safety extension study of Zerenex
Read More
ImmunoGen confirms fifth new ADC license agreement this year
Read More
AbbVie prepares new BRD4 inhibitors
Read More
SIRT1 activation as a putative strategy for the treatment of Huntington's disease
Read More
Revalesio begins phase IIa study of RNS-60 in multiple sclerosis
Read More
Allied Healthcare confirms first sale of CardioCel in Europe
Read More
Shield Therapeutics files IND for pivotal study of ST-10
Read More
Ohr Pharmaceutical patents novel PTP-1B inhibitors
Read More
Researchers report novel replication-competent vesicular stomatitis viruses for cancer
Read More
Mirrx Therapeutics and Centenary Institute enter agreement
Read More
Helsinn grants Chugai commercialization rights for anamorelin in select European markets
Read More
Chinese researchers patent novel antitumor drugs
Read More
Kyowa Hakko Kirin discontinues phase II studies of bardoxolone methyl
Read More
DSMB recommends continuation of phase IIb study of Graspa in AML
Read More
GSK reports topline results from phase III study of darapladib in chronic coronary heart disease
Read More